Tropical Diseases Archives

U.S. FDA Approves Lampit for Chagas Disease in Children

Antibody Tests, Approvals, Chagas Disease, Children, Endemic, FDA, FDA/Regulatory, Latin America, Pediatric Patients, Tropical Diseases, United States

The United States Food and Drug Administration approved Bayer’s Lampit (nifurtimox) for use in pediatric patients for the treatment of Chagas disease caused by Trypanosoma cruzi.

U.S. FDA Approves Moxidectin For The Treatment Of River Blindness

River Blindness (Onchocerciasis)

Medicines Development for Global Health and the World Health Organization Special Programme for Research and Training in Tropical Diseases announced that the U.S. FDA approved moxidectin 8 mg oral for the treatment of river blindness (onchocerciasis) in patients aged 12 years and older.

Merck Donates $300,000 to Support Neglected Tropical Disease Elimination Efforts in Africa

Africa, Lymphatic Filariasis (LF), River Blindness (Onchocerciasis), Tropical Diseases

Merck announced today a $300,000 cash donation to support non-governmental organization partners working to eliminate river blindness (onchocerciasis) and lymphatic filariasis (LF) in Africa.